Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
    Datensatz exportieren als...
  • BibTeX
Fluorinov Pharma, FACIT and OICR Announce Novel Candidate Drugs Modulating NaV 1.8, NaV 1.7 Sodium Channels for the Safer Treatment of Cancer Pain and Brain Cancer-Related Epilepsy
Business Wire, 2014
2014
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Convergence Pharmaceuticals' Novel Nav1.7 Selective Sodium Channel Blocker CNV1014802 Demonstrates Proof of Concept in Second Neuropathic Pain Study in Lumbosacral Radiculopathy
PR Newswire, 2014
2014
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Nektar Presents Positive Preclinical Data for NKTR-171, A Novel Sodium Channel Blocker to Treat Neuropathic Pain, at 41st Annual Meeting of the Society for Neuroscience: NKTR-171 Demonstrates Dose-Dependent Analgesia with Significantly Reduced CNS-Related Side Effects in Preclinical Studies
PR Newswire, 2012
2012
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
ASRI Announces Groundbreaking Discovery: Bifunctional 5-HT2A Antagonist and Sodium Channel Blocker Holds Promise for Bipolar Disorder Treatment
PR Newswire, 2024
2024
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V): Long-term data presented at American Epilepsy Society annual meeting demonstrate sustained efficacy and consistent tolerability profile; - Rates of cognitive adverse events similar to those associated with placebo; - Novel mechanism of action differs from traditional sodium channel agents; - Experts comment on Vimpat's role in treatment paradigm
PR Newswire, 2009
2009
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Asana BioSciences Announces Topical Sodium Channel Blocker ASN008 Achieves Positive Results for the Treatment of Pruritus in Atopic Dermatitis; and Provides Update on JAK/SYK Inhibitor Gusacitinib in Phase 2 Studies for Chronic Hand Eczema and AD
Business Wire, 2020
2020
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy: Neurocrine Biosciences Gains Rights to XEN901, a Clinical Stage Selective Nav1.6 Sodium Channel Inhibitor, Being Developed for the Treatment of Epilepsy
PR Newswire, 2019
2019
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Convergence Pharmaceuticals' Novel Sodium Channel Blocker CNV1014802 Shows Excellent Efficacy and Safety in Ground-breaking Phase II Trigeminal Neuralgia Study
PR Newswire, 2014
2014
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
First Subjects Dosed in Phase 1 Clinical Study of NKTR-171, A New Peripherally-Restricted Sodium Channel Blocker to Treat Neuropathic Pain
PR Newswire, 2014
2014
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Newron announces encouraging preliminary results of its Phase IIa study with Evenamide in patients with schizophrenia
Business Wire, 2017
2017
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Mechanism That Causes Epilepsy Demonstrated in Mammalian Neurons; 'Leaky' Sodium Channel Makes Brain Prone to Seizures
PR Newswire, 2002, p.1
2002
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
SiteOne Therapeutics Awarded up to $15M Grant to Develop NaV1.8 Inhibitor as Non-Opioid Therapeutic for Pain
PR Newswire, 2023
2023
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Drug Treatment Triggers Sodium Ions to Regenerate Nerves, Muscle
FARS News Agency, 2010
2010
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Jazz Pharmaceuticals Announces Second Quarter 2022 Financial Results and Affirms 2022 Financial Guidance
PR Newswire, 2022
2022
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Global Cancer Vaccines Market Share Is Expected To Reach $19.27 Billion By 2030
PR Newswire, 2023
2023
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Jazz Pharmaceuticals Announces First Quarter 2022 Financial Results and Raises 2022 Financial Guidance
PR Newswire, 2022
2022
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
JAZZ PHARMACEUTICALS ANNOUNCES FULL YEAR AND FOURTH QUARTER 2021 FINANCIAL RESULTS
PR Newswire, 2022
2022
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Parion Sciences Receives FDA Acceptance of the Investigational New Drug Application for Clinical Testing of P-321 Ophthalmic Solution for the Treatment of Dry Eye Disease: Initiation of Phase 1/2a clinical trial in subjects with dry eye disease expected mid-2014
PR Newswire, 2014
2014
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Jazz Pharmaceuticals Announces First Quarter 2021 Financial Results: Strong Xywav™ Adoption With 3,900 Active Xywav Patients Exiting The First Quarter
PR Newswire, 2021
2021
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Jazz Pharmaceuticals Announces Second Quarter 2021 Financial Results: Closed GW Pharmaceuticals plc Acquisition, Creating an Innovative, High-Growth, Global Biopharma Leader
PR Newswire, 2021
2021
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Antacids Market Projected to Reach $10.18 billion by 2030 - Exclusive Report by 360iResearch
PR Newswire, 2024
2024
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Purdue Pharma and AnaBios Collaborate to Advance Research for Non-Opioid, Non-NSAID Treatments for Chronic Pain
Business Wire, 2016
2016
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Newron Presents Encouraging Detailed Results of Its Phase IIa Study with Evenamide in Patients with Schizophrenia
Business Wire, 2017
2017
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Millennium and Wyeth-Ayerst Identify Gene That Modulates Key Ion Channel Involved in Disorders of the Central Nervous System
PR Newswire, 1998, p.1
1998
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
www.standoutstocks.com: Stocks That Stand Out For Dec. 15th, 2009 Are Dec 15, 2009 - NuMobile, Inc. (OTC Bulletin Board: NUBL), Dec 15, 2009 - Jazz Pharmaceuticals, Inc. (PinkSheets: JAZZ), Dec 14, 2009 - United Treatment Centers Inc. (PINKSHEETS: UTRM), Dec 14, 2009 - RMD Entertainment Group's (PinkSheets: RMDM), Dec 14, 2009 - Green Energy Live Inc. (OTC Bulletin Board: GELV)
M2 Presswire, 2009
2009
Link zum Volltext
Verfügbarkeit prüfen
1 – 25 von 768
Suche als RSS-Feed
Aktive Filter
KollektionTaylor & Francis E-Journals
SpracheJapanisch
PublikationsformReferenzeintrag
ThemaPhysiology
PublikationsformNewsletter-Artikel
Suchergebnisse filtern
Filter anzeigen